Introduction {#s1}
============

Production of antimicrobial compounds is an important strategy to increase competitiveness of soil bacteria. Soil is a heterogeneous, nutrient-poor and harsh environment harboring a huge diversity of bacteria (Gans et al., [@B17]; Uroz et al., [@B51]). There is also considerable functional redundancy as many soil bacterial species can use similar substrates as an energy source for growth and persistence (Yin et al., [@B55]; Strickland et al., [@B49]). Therefore, inter-specific competition for nutrient resources is a major type of interaction in soil bacterial communities (Demoling et al., [@B12]; Rousk and Baath, [@B38]; Rousk et al., [@B39]). An important strategy in interspecific interactions, known as interference competition, is the production of growth inhibitory secondary metabolites (e.g., antibiotics, toxins, biosurfactants, volatiles and others) that can suppress or kill microbial opponents (Hibbing et al., [@B25]; Cornforth and Foster, [@B5]). Although the production of antimicrobial compounds could inhibit the growth of bacterial strains competing for resources, in some cases the produced antimicrobial compounds could also promote the growth of other bacteria (D\'costa et al., [@B8]; Dantas et al., [@B6]), act as signaling molecules (Linares et al., [@B29]; Romero et al., [@B37]) or modulate bacterial gene expression in sub inhibitory concentrations (Goh et al., [@B22]).

Whole genome sequencing has revealed that many soil microorganisms possess so-called cryptic gene clusters encoding for putative new secondary metabolites that are not produced during common *in vitro* conditions (Ikeda et al., [@B26]; Scherlach and Hertweck, [@B42]; Chiang et al., [@B3]; Saleh et al., [@B40]). In nature, however, antibiotics may be produced after perception of specific environmental signals (stress/nutrient signals) or signals from neighboring microorganisms (competitor sensing) (Firn and Jones, [@B16]; Cornforth and Foster, [@B5]; Zhu, [@B56]). Indeed, several studies have indicated that antibiotic production in soil bacteria can be induced when they are confronted with other bacterial species (Slattery et al., [@B47]; Lyon and Muir, [@B30]; Maurhofer et al., [@B31]; De Boer et al., [@B9]; Seyedsayamdost et al., [@B44]). We hypothesize that competitor induced (facultative) rather than constitutive antibiotic production represents a key strategy in interference competition that is cost-effective and/or may reduce selection of antibiotic-resistant competitors (Garbeva et al., [@B20]). Interaction-mediated induction of antibiotic production is also interesting from an applied perspective as it may lead to the discovery of novel antibiotics.

The aim of the current study was to obtain insight in the frequency of interaction-mediated induction of antibiotic production in natural soil bacterial communities. To this end, we screened a collection of bacterial isolates obtained from similar soil habitats. We developed and applied a high-throughput method to screen bacteria for the production of compounds that inhibit growth of Gram-positive and Gram-negative isolates that are closely related to human pathogens. By selecting these target organisms the study not only revealed information on the frequency of interaction-mediated antibiotic production, but also on specific soil bacterial genera or species that could be promising candidates for the discovery of novel antibiotics. The obtained results revealed that interactions have a major impact on antimicrobial compound production albeit with effects in both directions i.e., induction and suppression of antimicrobial activity.

Materials and methods {#s2}
=====================

Soil bacteria and culture conditions
------------------------------------

We selected 146 bacterial isolates from organic-poor, sandy soils under vegetation patches of sand sedge (*Carex arenaria* L.) growing in natural field sites (De Ridder-Duine et al., [@B13]) (Table [S1](#SM1){ref-type="supplementary-material"}). The bacterial isolates were pre-cultured from −80°C glycerol stocks on 1/10 TSBA (5.0 gL^−1^ NaCl, 1.0 gL^−1^ KH~2~PO~4~; 3 gL^−1^ Oxoid Tryptic Soy Broth; 20 gL^−1^ Merck Agar, pH 6.5) (Garbeva and De Boer, [@B18]) and incubated for 5--7 days at 20°C prior to screening.

Control strains and target organisms
------------------------------------

Reference strains that produce known antibiotics in monoculture were obtained from the DSMZ strain collection (Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany). These reference strains were: *Streptomyces kanamyceticus* (DSM 40500), producer of kanamycin, *Streptomyces rimosus* (DSM 40260), producer of oxytetracycline and *Streptomyces nodosus* (DSM 40109) producer of amphotericin A and B. These strains were pre-cultured from −80°C glycerol stocks on GYM agar plates (4.0 gL^−1^ Glucose, 4.0 gL^−1^ BACTO™ Yeast extract, 10.0 gL^−1^Malt extract, 2.0 gL^−1^ CaCO~3~, 20 gL^−1^ Merck Agar, pH 7.2) and incubated for 7 days at 28°C before inoculation into 96-well source plates (see below). In the agar-overlay assay, two bacterial strains were selected to act as model organisms for human pathogenic bacteria: *Escherichia coli* WA321 (DSM 4509) as Gram-negative target organism and *Staphylococcus aureus* 533R4 Serovar 3 (DSM 20231) as Gram-positive target organism. The target strains were pre-cultured from −80°C glycerol stocks on Luria Bertani (LB) agar plates (10.0 gL^−1^ NaCl, 10 gL^−1^ Bacto™ Tryptone, 5 gL^−1^ Bacto™ Yeast extract, 20 gL^−1^ Merck Agar) Sambrook and Russell ([@B41]) and incubated at 37°C for 24 h before inoculation in the antimicrobial screening assay. Characteristics of the target and the control strains are listed in Table [S3](#SM1){ref-type="supplementary-material"}.

Preparation of omnitray™ plates
-------------------------------

For the high-throughput interaction assay polystyrene Nunc™ OmniTray™---plates (size 128 × 86 mm; cap. 90 mL; Nunc™, Nalge Nunc International, Rochester, NY, USA Cat \# 82-264728) were used. Each OmniTray™ plate was filled with 45 mL of 1/10 TSBA (2%) agar. Plates were kept in the laminar flow cabinet until the agar was completely solidified.

Preparation of 96-well source-plates
------------------------------------

96-well Microtiter plates (Greiner bio-one B.V., Alphen a/d Rijn, The Netherlands, Cat\# 655180) were prepared to inoculate the selected bacterial isolates and the reference strains. Each well was filled with 150 μl liquid LB broth. Bacterial isolates were inoculated in 10 rows containing quadruplicates of each strain, the 11th row was kept empty and the 12th row was used as positive control by inoculating known antibiotic-producing *Streptomyces* strains in duplicate with one free well between each strain (Figure [1](#F1){ref-type="fig"}). Inoculation was done by picking cells from a single colony of each bacterial strain with a disposable inoculation loop (VWR international B.V., Amsterdam, The Netherlands Cat\# 50806-404) and transferring to the designated well in the 96-well source plates. The plates were incubated for 2 days at 24°C, after which the plates were prepared for long-term storage (−80°C freezer) by adding 50 μl of 50% (v/v) glycerol to achieve a final concentration of 12.5% (v/v). In total, 15 Microtiter plates (source plates A--O) containing different compositions of monocultures of bacterial isolates were prepared for the high-throughput interaction assay.

![**Workflow of the high-throughput interaction assay. (A)** Overview of the antimicrobial screening: bacteria were inoculated with a Genetix Qpix 2 colony picking robot either in monoculture or in one-to-one interactions on OmniTray™ plates. For the detection of antimicrobial activity an agar overlay assay with two target organisms was performed on the fourth day of incubation. Antimicrobial activity was determined on the 5th day after overnight incubation at 37°C by screening for visible zones of inhibition (ZOI) in the upper agar layer. **(B)** Overview of the 96-well plates design and the inoculation procedure using the Genetix QPix2 colony picking robot.](fmicb-05-00567-g0001){#F1}

High-throughput interaction assay
---------------------------------

A Genetix QPix 2 colony picking robot (Molecular Devices, UK Limited, Wokingham, United Kingdom) was used for the high-throughput interaction assay. The Genetix QPix 2 robot was mounted with a bacterial 96-pin picking head and programmed to replicate the source plates (96-well Microtiter plates) into the OmniTray™ plates (Figure [1](#F1){ref-type="fig"}). The source plates were replicated two times, one set of inoculated plates was removed from the robot and was used as control to estimate growth and antimicrobial activity of the monocultures. The remaining plates in the robot were used for the interaction assay by inoculating a second set of source-plates in various combinations. The second set of bacterial isolates was inoculated at the same position as the first set of bacteria, in this way the bacterial isolates had physical cell contact and could interact in one-to-one interactions (in quadruplicates). The inoculated OmniTray™ plates (monocultures and interaction plates) were incubated for 4 days at 24°C. In total, 146 bacterial isolates were combined with each other in various arrangements and tested in 2798 unique interactions for the production of antimicrobial compounds.

Antimicrobial screening
-----------------------

For detection of antimicrobial activity, an agar overlay assay was performed on the 4th day of incubation (Nkanga and Hagedorn, [@B33]). The two target organisms *E. coli* WA321 and *S. aureus* 533R4 were grown overnight in liquid LB broth at 37°C, 220 rpm. Fresh LB- agar (1.5% Merck Agar) was prepared, cooled down to \~45°C and the target organisms were added to a final OD~600~ of 0.002 corresponding to approximately 6 × 10^∧^5 CFU/mL (*E. coli* WA321) or 4 × 10^∧^5 CFU/mL (*S. aureus* 533R4) and mixed well. A volume of 15 mL liquid LB-agar containing the target organisms was poured over the OmniTray™ plates with the empty 11th row as the start position for pouring. After solidification of the overlay agar, the OmniTray™ plates were incubated overnight at 37°C. The next day (5th day), plates were examined for visible zones of inhibition (ZOI). Monocultures or mixed-cultures of the soil bacterial isolates were scored as positive for antibiotic production if at least two out of four replicates produced zones of inhibition (Figure [1A](#F1){ref-type="fig"}). The majority of activity reported (\>55%) involved ≥3 out of 4 replicates. For confirmation of the high-throughput screening results, several of the antibiotic-triggering/suppressing interactions were tested outside the HTS setup (Figures [S7](#SM1){ref-type="supplementary-material"}, [S8](#SM1){ref-type="supplementary-material"}).

PCR and 16S rRNA gene sequencing
--------------------------------

For identification of the bacterial isolates, PCRs were performed directly on colonies or with extracted genomic DNA. For genomic DNA extraction the QIAGEN QIAmp DNA Mini Kit (QIAGEN Benelux B.V., Venlo, The Netherlands cat\# 51 304) was applied according to the manufacturer\'s manual. For the colony PCRs, a few colonies of each bacterial isolate were scraped from the plate with a disposable inoculation loop (VWR international B.V., Amsterdam, The Netherlands Cat\# 50806-404) and re-suspended in 250 μl sterile MQ-water. The re-suspended bacterial cells were pulse vortexed and heated to 95°C for 5 min. Tubes were centrifuged for 3 min at 12,000×g and 1 μl supernatant from each bacterial isolate was applied in a 50 μl PCR- master mix (Promega Corp. Madison, USA cat\# M7505). For 16S rRNA gene amplification, one of the two primer combinations was used: (1) forward primer pA (5′- AGA GTT TGA TCC TGG CTC AG -3′), reverse primer 1492r (5′- GRT ACC TTG TTA CGA CTT -3′), amplifying \~1492 bp from the 16S rRNA gene or (2) forward primer 27f (5′- AGA GTTT GAT CMT GGC TCAG -3′), reverse primer 1492r amplifying \~1465 bp from the 16S rRNA gene (Edwards et al., [@B15]; Lane, [@B28]) (modified). All PCR reactions were performed on a MJ Research Peltier thermal cycler 200 PCR machine (Harlow Scientific, Arlington, USA) with the following settings: initial cycle 95°C for 5 min. and 30 cycles of 94°C for 30 sec., 55°C for 30 sec. and 72°C for 1 min. After amplification, a volume of 5 μl of each PCR reaction was loaded on a 1.25 % (w/v) agarose gel and checked after electrophoresis for presence of PCR fragment. The PCR products were sent to MACROGEN (MACROGEN Europe, Amsterdam, The Netherlands) for sequencing.

Phylogenetic analysis and sequence analysis
-------------------------------------------

Obtained sequence chromatograms of the 16S rRNA gene were examined for quality and trimmed to approximately the same size (\~650 bp) using 4 PEAKS V1.7.2 for MAC OS X ([www.nucleobytes.com](http://www.nucleobytes.com)) © 2006 Mek&Tosj.com and Clustal W. The aligned 16S rRNA gene sequences were compared against those available in the NCBI database by BLASTN (blast.ncbi.nlm.nih.gov) (Altschul et al., [@B1]). The sequences obtained during this study are deposited in NCBI GenBank under accession numbers KJ685218--KJ685361. For two isolates, the 16S rRNA sequences were available from previous work: *P. fluorescens* (strain AD21): DQ778036, *Pedobacter* sp. (strain V48): DQ778037 (De Boer et al., [@B10]).

Network visualization of interactions
-------------------------------------

The bacterial interaction pairs that triggered or suppressed antimicrobial activity against the target organisms were visualized with Cytoscape 3.0.2 ([www.cytoscape.org](http://www.cytoscape.org)) for MAC OS X (Shannon et al., [@B45]). Interaction visualizations were performed with the following parameters: each phylogenetic class was visualized as a single node with different symbols for each phylogenetic class, the interactions between the phylogenetic classes (nodes) were visualized by links (edges) connecting each interacting phylogenetic class. Node colors were scaled to the number of interactions between the different phylogenetic classes (see Figure legends). For visualization, self-loops (interactions within the same phylogenetic class) and edges (interactions between phylogenetic classes) were bundled to single links between the respective phylogenetic classes (the darker the line the higher the number of interactions between the phylogenetic classes).

Statistical analysis
--------------------

Statistical analyses on frequencies for induction and/or suppression of antimicrobial compound production between the different Gram-groups were performed with <http://math.hws.edu/javamath/ryan/ChiSquare.html> using online chi square tests. Results of the chi-square test are shown in Tables [S5](#SM1){ref-type="supplementary-material"}, [S6](#SM1){ref-type="supplementary-material"}.

Results {#s3}
=======

Phylogeny of the tested bacterial isolates
------------------------------------------

16S rRNA gene sequence analysis revealed that the 146 bacterial isolates tested in this study belonged to 4 phyla covering 7 classes and 9 genera: Proteobacteria (14 alpha-Proteobacteria, 65 beta-Proteobacteria, 29 gamma-Proteobacteria), Bacteroidetes (19 Flavobacteria, 1 Sphingobacteria), Actinobacteria (11 Actinobacteria) and Firmicutes (7 Bacilli) (Table [1](#T1){ref-type="table"} and Table [S1](#SM1){ref-type="supplementary-material"}).

###### 

**Frequencies of antimicrobial activity for the phyla included in this study**.

  **Phylum/phylogenetic class**   **Total abundance**   **AM active vs. *E. coli* in monoculture**   **AM active vs. *E. coli* in interaction**   **AM active vs. *S. aureus* in monoculture**   **AM active vs. *S. aureus* in interaction**
  ------------------------------- --------------------- -------------------------------------------- -------------------------------------------- ---------------------------------------------- ----------------------------------------------
  Actinobacteria                                                                                                                                                                                 
    Actinobacteria                11                    3                                            3                                            4                                              5
  Bacteroidetes                                                                                                                                                                                  
    Flavobacteria                 19                    1                                            3                                            3                                              11
    Sphingobacteria               1                                                                  1                                                                                           
  Firmicutes                                                                                                                                                                                     
    Bacilli                       7                     2                                            2                                            3                                              2
  Proteobacteria                                                                                                                                                                                 
    a-proteobacteria              14                                                                 1                                            3                                              9
    β-proteobacteria              65                    17                                           8                                            26                                             25
    γ-proteobacteria              29                    2                                            2                                            12                                             7
  \(n\) isolates                  146                   25                                           20                                           51                                             59

High-throughput screening for antimicrobial activity
----------------------------------------------------

We developed a high-throughput assay to screen for production of antimicrobial compounds by interacting bacteria (Figure [1](#F1){ref-type="fig"}). In total 146 isolates were screened in monocultures and in 2798 random one-to-one interactions. For 17 isolates (11%), no activity against *E. coli* and *S. aureus* was detected not in monocultures nor in mixed cultures (Table [S1](#SM1){ref-type="supplementary-material"} and Figure [2A](#F2){ref-type="fig"}). For 20 isolates (14%) antibacterial activity was observed in both monoculture and mixed cultures. For 48 isolates (33%), this was restricted to monocultures only and for 61 isolates (42%) antibacterial activity was only apparent during interactions (Figures [2A](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). The number of isolates (110) involved in activity against the Gram-positive target strain *S. aureus* 533R4 was more than twice the number of isolates (45) with activity against the Gram-negative target strain *E. coli* WA321 (Table [1](#T1){ref-type="table"}, Table [S1](#SM1){ref-type="supplementary-material"}). Despite the high number of bacterial isolates involved in antimicrobial activity in interactions, the frequency of interaction-mediated induction of antimicrobial activity was low \~6% (154 interactions out of 2798). This implies that interaction-mediated induction was only occurring in a limited number of combinations (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). Most interactions (72%) did not have an effect on antimicrobial activity (induction or suppression) and about 22% of the interactions suppressed antimicrobial activity in isolates that revealed activity in monoculture (Figure [2B](#F2){ref-type="fig"}).

![**(A)** Number of bacterial isolates exhibiting different patterns of antimicrobial activity against *E. coli* WA321 and/or *S. aureus* 533R4; in total 146 bacterial isolates were studied **(B)** Frequencies of interactions (1) inducing antimicrobial activity, (2) suppressing antimicrobial activity and (3) neutral interactions (no induction/suppression). Number of tested combinations (*n* = 2798).](fmicb-05-00567-g0002){#F2}

![**Example of antimicrobial activity revealed via the agar overlay assay**. *Burkholderia* sp. AD24 monoculture **(A)**, *Paenibacillus* sp. AD83 monoculture **(B)**, Interaction *Burkholderia* sp. AD24 with *Paenibacillus* sp. AD83 antimicrobial activity against *S. aureus* 533R4 **(C)** and antimicrobial activity against *E. coli* WA321 **(D)**.](fmicb-05-00567-g0003){#F3}

###### 

**Bacterial pairs with induced antimicrobial activity against *E. coli* WA 321**.

  **Phylogenetic class**   **Genus A**                    **Phylogenetic class**   **Genus B**
  ------------------------ ------------------------------ ------------------------ ------------------------------
  alpha-proteobacteria     *Phyllobacterium* sp. AD152    gamma-proteobacteria     *Pseudomonas* sp. AD114
  beta-proteobacteria      *Burkholderia* sp. AD24        beta-proteobacteria      *Collimonas* sp. AD68
  beta-proteobacteria      *Burkholderia* sp. AD32        beta-proteobacteria      *Janthinobacterium* sp. AD80
  beta-proteobacteria      *Janthinobacterium* sp. AD72   Flavobacteria            *Flavobacterium* sp. AD151
  beta-proteobacteria      *Janthinobacterium* sp. AD80   gamma-proteobacteria     *Dyella* sp. AD56
  beta-proteobacteria      *Janthinobacterium* sp. AD80   beta-proteobacteria      *Variovorax* sp. AD133
  Actinobacteria           *Streptomyces* sp. AD108       beta-proteobacteria      *Burkholderia* sp. AD37
  Actinobacteria           *Streptomyces* sp. AD108       Flavobacteria            *Flavobacterium* sp. AD47
  Actinobacteria           *Streptomyces* sp. AD108       Flavobacteria            *Flavobacterium* sp. AD84
  Actinobacteria           *Streptomyces* sp. AD108       Sphingobacteria          *Pedobacter* sp. V48
  Actinobacteria           *Microbacterium* sp. AD141     beta-proteobacteria      *Janthinobacterium* sp. AD80
  Bacilli                  *Bacillus* sp. AD78            beta-proteobacteria      *Burkholderia* sp. AD11
  Bacilli                  *Paenibacillus* sp. AD83       beta-proteobacteria      *Burkholderia* sp. AD24
  Actinobacteria           *Micrococcus* sp. AD31         Actinobacteria           *Microbacterium* sp. AD141

###### 

**Bacterial pairs with induced antimicrobial activity against *S. aureus* 533R4**.

  **Phylogenetic class**   **Genus A**                    **Phylogenetic class**   **Genus B**
  ------------------------ ------------------------------ ------------------------ ------------------------------
  alpha-proteobacteria     *Phyllobacterium* sp. AD34     beta-proteobacteria      *Collimonas* sp. AD89
  alpha-proteobacteria     *Phyllobacterium* sp. AD153    beta-proteobacteria      *Collimonas* sp. AD65
  beta-proteobacteria      *Collimonas* sp. AD69          Flavobacteria            *Flavobacterium* sp. AD43
  beta-proteobacteria      *Janthinobacterium* sp. AD72   gamma-proteobacteria     *Dyella* sp. AD46
  beta-proteobacteria      *Janthinobacterium* sp. AD72   beta-proteobacteria      *Collimonas* sp. AD97
  beta-proteobacteria      *Janthinobacterium* sp. AD72   alpha-proteobacteria     *Agrobacterium* sp. AD140
  beta-proteobacteria      *Collimonas* sp. AD61          beta-proteobacteria      *Collimonas* sp. AD98
  beta-proteobacteria      *Collimonas* sp. AD67          beta-proteobacteria      *Collimonas* sp. AD68
  beta-proteobacteria      *Janthinobacterium* sp. AD75   beta-proteobacteria      *Burkholderia* sp. AD37
  beta-proteobacteria      *Collimonas* sp. AD69          Flavobacteria            *Flavobacterium* sp. AD146
  beta-proteobacteria      *Collimonas* sp. AD71          alpha-proteobacteria     *Rhizobium* sp. AD148
  beta-proteobacteria      *Collimonas* sp. AD88          beta-proteobacteria      *Burkholderia* sp. AD37
  beta-proteobacteria      *Collimonas* sp. AD102         Flavobacteria            *Flavobacterium* sp. AD45
  beta-proteobacteria      *Collimonas* sp. AD98          Flavobacteria            *Flavobacterium* sp. AD142
  beta-proteobacteria      *Burkholderia* sp. AD37        gamma-proteobacteria     *Pseudomonas* sp. AD104
  beta-proteobacteria      *Collimonas* sp. AD99          beta-proteobacteria      *Burkholderia* sp. AD138
  beta-proteobacteria      *Collimonas* sp. AD89          alpha-proteobacteria     *Mesorhizobium* sp. AD38
  beta-proteobacteria      *Variovorax* sp. AD143         beta-proteobacteria      *Collimonas* sp. AD65
  beta-proteobacteria      *Variovorax* sp. AD143         alpha-proteobacteria     *Mesorhizobium* sp. AD112
  beta-proteobacteria      *Variovorax* sp. AD143         alpha-proteobacteria     *Phyllobacterium* sp. AD153
  beta-proteobacteria      *Collimonas* sp. AD98          alpha-proteobacteria     *Phyllobacterium* sp. AD159
  beta-proteobacteria      *Collimonas* sp. AD98          gamma-proteobacteria     *Pseudomonas* sp. AD105
  beta-proteobacteria      *Collimonas* sp. AD137         gamma-proteobacteria     *Pseudomonas* sp. AD157
  beta-proteobacteria      *Collimonas* sp. AD97          beta-proteobacteria      *Collimonas* sp. AD62
  beta-proteobacteria      *Roseateles* sp. AD145         beta-proteobacteria      *Collimonas* sp. AD67
  gamma-proteobacteria     *Pseudomonas* sp. AD124        beta-proteobacteria      *Collimonas* sp. AD65
  gamma-proteobacteria     *Pseudomonas* sp. AD114        beta-proteobacteria      *Burkholderia* sp. AD18
  gamma-proteobacteria     *Pseudomonas* sp. AD105        alpha-proteobacteria     *Bosea* sp. AD132
  gamma-proteobacteria     *Pseudomonas* sp. AD104        alpha-proteobacteria     *Phyllobacterium* sp. AD136
  gamma-proteobacteria     *Pseudomonas* sp. AD104        Flavobacteria            *Chryseobacterium* sp. AD48
  Flavobacteria            *Flavobacterium* sp. AD91      beta-proteobacteria      *Variovorax* sp. AD143
  Flavobacteria            *Flavobacterium* sp. AD91      alpha-proteobacteria     *Phyllobacterium* sp. AD153
  Flavobacteria            *Flavobacterium* sp. AD42      Flavobacteria            *Flavobacterium* sp. AD146
  Flavobacteria            *Flavobacterium* sp. AD155     beta-proteobacteria      *Collimonas* sp. AD98
  Flavobacteria            *Flavobacterium* sp. AD44      beta-proteobacteria      *Collimonas* sp. AD62
  Actinobacteria           *Micrococcus* sp. AD31         beta-proteobacteria      *Collimonas* sp. AD65
  Actinobacteria           *Micrococcus* sp. AD31         beta-proteobacteria      *Collimonas* sp. AD69
  Actinobacteria           *Micrococcus* sp. AD31         beta-proteobacteria      *Collimonas* sp. AD70
  Actinobacteria           *Micrococcus* sp. AD31         Flavobacteria            *Flavobacterium* sp. AD85
  Actinobacteria           *Micrococcus* sp. AD31         beta-proteobacteria      *Collimonas* sp. AD88
  Actinobacteria           *Micrococcus* sp. AD31         alpha-proteobacteria     *Phyllobacterium* sp. AD136
  Actinobacteria           *Micrococcus* sp. AD31         gamma-proteobacteria     *Stenotrophomonas* sp. AD147
  Actinobacteria           *Micrococcus* sp. AD31         Flavobacteria            *Flavobacterium* sp. AD156
  Actinobacteria           *Streptomyces* sp. AD92        beta-proteobacteria      *Collimonas* sp. AD65
  Actinobacteria           *Streptomyces* sp. AD92        beta-proteobacteria      *Variovorax* sp. AD143
  Actinobacteria           *Streptomyces* sp. AD92        beta-proteobacteria      *Burkholderia* sp. AD18
  Actinobacteria           *Streptomyces* sp. AD92        alpha-proteobacteria     *Phyllobacterium* sp. AD153
  Actinobacteria           *Tsukamurella* sp. AD106       beta-proteobacteria      *Collimonas* sp. AD89
  Actinobacteria           *Tsukamurella* sp. AD106       Flavobacteria            *Chryseobacterium* sp. AD48
  Actinobacteria           *Streptomyces* sp. AD108       beta-proteobacteria      *Burkholderia* sp. AD37
  Actinobacteria           *Streptomyces* sp. AD108       Flavobacteria            *Chryseobacterium* sp. AD48
  Actinobacteria           *Streptomyces* sp. AD108       beta-proteobacteria      *Janthinobacterium* sp. AD73
  Actinobacteria           *Streptomyces* sp. AD108       beta-proteobacteria      *Janthinobacterium* sp. AD75
  Actinobacteria           *Streptomyces* sp. AD108       beta-proteobacteria      *Collimonas* sp. AD88
  Actinobacteria           *Streptomyces* sp. AD108       beta-proteobacteria      *Collimonas* sp. AD101
  Actinobacteria           *Streptomyces* sp. AD108       gamma-proteobacteria     *Pseudomonas* sp. AD104
  Actinobacteria           *Microbacterium* sp. AD141     beta-proteobacteria      *Burkholderia* sp. AD37
  Bacilli                  *Paenibacillus* sp. AD83       beta-proteobacteria      *Collimonas* sp. AD62
  Bacilli                  *Paenibacillus* sp. AD83       beta-proteobacteria      *Burkholderia* sp. AD24
  Bacilli                  *Paenibacillus* sp. AD116      gamma-proteobacteria     *Pseudomonas* sp. AD104
  Actinobacteria           *Micrococcus* sp. AD31         Actinobacteria           *Tsukamurella* sp. AD106
  Actinobacteria           *Tsukamurella* sp. AD106       Actinobacteria           *Microbacterium* sp. AD141
  Actinobacteria           *Streptomyces* sp. AD108       Actinobacteria           *Microbacterium* sp. AD141

Antimicrobial activity during interactions
------------------------------------------

### Interaction-mediated activity against E. coli WA321

Growth of *E. coli* WA321 was inhibited by 14 pair-wise combinations involving 20 isolates that did not show antimicrobial activity in monoculture (Table [2](#T2){ref-type="table"}). Some isolates were present in different combinations. For example, *Janthinobacterium* sp. AD80 and *Streptomyces* sp. AD108 were present in 4 combinations with induced activity (Table [2](#T2){ref-type="table"}). Combinations inhibiting growth of *E. coli* WA321 consisted of Gram-negative/Gram-positive isolates (7 interactions) or Gram-negative/Gram-negative (6 interactions). Only in one case, a combination of two Gram-positive isolates (*Micrococcus* and *Microbacterium*) showed activity against *E. coli*.

### Interaction-mediated activity against S. aureus 533R4

Growth of *S. aureus* 533R4 was inhibited by 63 pair-wise combinations involving 59 isolates. Several isolates were present in multiple combinations that inhibited growth of *S. aureus* (Table [3](#T3){ref-type="table"}). *Burkholderia* sp. AD37, *Collimonas* sp. AD65, *Collimonas* sp. AD98, *Janthinobacterium* sp. AD72, *Micrococcus* sp. AD31, *Pseudomonas* sp. AD104, *Streptomyces* spp. AD92 and AD108, *Variovorax* sp. AD143 were all involved in more than five combinations that inhibited the growth of *S. aureus*. Most of the combinations consisted of Gram-negative/Gram-negative isolates (35 interactions) or Gram-negative/Gram-positive isolates (25 interactions). Activity against *S. aureus* was only observed 3 times for Gram-positive/Gram-positive combinations (Figure [S2](#SM1){ref-type="supplementary-material"}).

### Interaction-mediated activity against both target organisms

Nine isolates were present in pair-wise combinations that exhibited antimicrobial activity against both target organisms (Table [S1](#SM1){ref-type="supplementary-material"}). Two combinations were inhibitory for both target organisms. These were the combinations of *Burkholderia* sp. AD24 and *Paenibacillus* sp. AD83 (Figure [3](#F3){ref-type="fig"}) and of *Streptomyces* sp. AD108 and *Burkholderia* sp. AD37.

### Interactions inducing antimicrobial activity against E. coli or S. aureus

The number of pair-wise combinations with induced antimicrobial activity against *S. aureus* 533R4 was higher than against *E. coli* WA321. Most combinations with induced activity against *E. coli* WA321 involved beta-Proteobacteria, Actinobacteria, Flavobacteria, and Bacilli (Figure [4A](#F4){ref-type="fig"}). Combinations with induced activity against *S. aureus* 533R4 involved all classes of Proteobacteria, Actinobacteria, Flavobacteria, and Bacilli (Figure [4B](#F4){ref-type="fig"}). Two phylogenetic classes, Flavobacteria and alpha--Proteobacteria, were 3 times more represented in pair-wise combinations with antimicrobial activity than in monocultures (Table [1](#T1){ref-type="table"}).

![**Interactions between phylogenetic classes that induced antimicrobial activity against (A) the Gram-negative target organism *E. coli* WA321, or (B) against the Gram-positive target organism *S. aureus* 533R4**. Node colors are scaled to the number of interactions between the phylogenetic classes, low number of interactions in bright green, high number of interactions in dark red (see color bar).](fmicb-05-00567-g0004){#F4}

### Interactions suppressing antimicrobial activity against E. coli or S. aureus

22% of the isolates with antimicrobial activity in monoculture lost this activity during interactions. This apparent suppression of antimicrobial activity was found among all bacterial classes included in this study (Figures [5A,B](#F5){ref-type="fig"}). Suppression of antimicrobial activity was more frequently found for *S. aureus* than for *E. coli* (Figure [3B](#F3){ref-type="fig"}). The lists of bacterial pairs which suppressed antimicrobial activity against *S. aureus* and/or *E. coli* are shown in Tables [S9](#SM1){ref-type="supplementary-material"}, [S10](#SM1){ref-type="supplementary-material"}.

![**Interactions between phylogenetic classes that inhibited antimicrobial activity against (A) the Gram-negative target organism *E. coli* WA321, or (B) against the Gram-positive target organism *S. aureus* 533R4**. Node colors are scaled to the respective number of interactions between the phylogenetic classes (low number of interactions in bright colors, high number of interactions in dark colors).](fmicb-05-00567-g0005){#F5}

Discussion {#s4}
==========

Recent studies indicated the importance of interspecific bacterial interactions for triggering antibiotic production (Garbeva et al., [@B19]; Seyedsayamdost et al., [@B44]). However, the frequency of such events in natural bacterial communities is not known. Our study focused on a collection of bacterial isolates from similar soil habitats, i.e., sandy soils covered by vegetation patches consisting of sand sedge (*C. arenaria*). Hence, the chance that actual interactions between these bacteria can occur in their natural habitat seems plausible. Induction of antibiotic production in pair-wise combinations was not found to be an abundant phenomenon as it occurred in \~6% of all interactions studied. Yet, 42% of the bacterial isolates were present in combinations that showed activity against at least one of the target organisms, whereas they did not show activity in monocultures. This seems to indicate that the composition of the interacting pairs is an important factor in the induction of antibiotic production.

The observed frequency of interaction-mediated induction of antibiotic production exemplifies that a high-throughput screening as the one developed here can be an important strategy for the discovery of novel cryptic antibiotics. Many pair-wise combinations have to be screened and, subsequently, interesting pairs can be studied in more detail with respect to elucidate the mechanisms underlying the induction, signals and genes involved in the production of the antibiotic compounds (Garbeva et al., [@B19]; Traxler et al., [@B50]). Interactions that induced antimicrobial activity often involved combinations of phylogenetically different bacteria or interactions among beta-Proteobacteria and among Actinobacteria. The present work included several bacterial genera (e.g., *Streptomyces*, *Burkholderia*, *Janthinobacterium* and *Paenibacillus*) for which multiple antibiotics have been described previously (Pantanella et al., [@B34]; Berdy, [@B2]; Cornforth and Foster, [@B5]; Debois et al., [@B11]; Zhu, [@B56]). Hence, there is the possibility that our screening method will reveal bacteria that produce known antibiotics but only during co-cultivation.

Few bacterial isolates of the classes Flavobacteria and alpha- Proteobacteria showed antimicrobial activity in monoculture, whereas several strains were present in antibiotic producing combinations. Hence, for these groups there is a clear potential to discover novel antibiotics. Of the 146 tested isolates, 33% showed antimicrobial activity in monoculture. This obtained frequency is in line with previous studies on frequencies of antimicrobial activity in *Streptomyces* spp. (Davelos et al., [@B7]; Kinkel et al., [@B27]). However, in many cases antibiotic production was lost when the strain was combined with another strain and only a small percentage (13%) kept their antimicrobial activity in both combinations and monoculture. This suppressing effect on antibiotic production was more often found (22% of all combinations) than the induction of antibiotic production (\~6% of all combinations). Several mechanisms can be responsible for the observed suppression of antimicrobial activity during interactions e.g., interference with the quorum sensing system or other signal transduction pathways involved in regulating antibiotic production (Gonzalez and Keshavan, [@B23]; Venturi and Subramoni, [@B53]; Christensen et al., [@B4]) or direct growth inhibition of the antibiotic producing strain (Straight et al., [@B48]; Hibbing et al., [@B25]; Schneider et al., [@B43]). Another possible reason for the observed inhibition of antimicrobial activity during interactions could be lower nutrient availability for each strain during co-cultivation. Growth conditions and nutrient availability are important factors affecting the production of antimicrobial compounds in bacteria (van Wezel and McDowall, [@B52]). Antibiotic resistance mechanisms might also play a role in the observed inhibition of antimicrobial activity during co-cultivation (Rice, [@B36]; Wellington et al., [@B54]).

Depending on the target organism there was a clear difference in antimicrobial activity with higher activity against the Gram-positive than against the Gram-negative organism (in both monocultures and interactions), which is in line with previous reports that Gram-positive bacteria are generally more sensitive to antibiotics (Rice, [@B36]; Giske et al., [@B21]; Zhu, [@B56]).

Soil and rhizosphere are environments where bacteria evolved the ability to produce antibiotics as competitive tool for their survival (Hibbing et al., [@B25]). Root-associated bacteria with antimicrobial potential play an important role in plant health (Raaijmakers and Mazzola, [@B35]) and understanding microbial interactions affecting antimicrobial activity may be helpful in understanding the functions and mechanisms of microbial communities contributing to plant protection. The knowledge obtained here could help in selecting the right players in microbial consortia and as suggested by Mendes (Mendes et al., [@B32]) to design "a minimal microbiome" that comprises a set of microorganisms needed to fulfill a specific ecosystem services like e.g., disease suppression.

In conclusion, the high-throughput screening method developed in this work allows for a fast detection of interaction-mediated induction or suppression of antibiotic production in soil bacteria. Such screening also allows for a better insight into different interference competitive strategies that are operational in microbial communities. This knowledge in turn can be used for construction of synthetic microbial communities (Shong et al., [@B46]; De Roy et al., [@B14]; Grosskopf and Soyer, [@B24]).
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